Novavax, Inc. and Isconova to Combine; Novavax' Swedish Prospectus Approved
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ROCKVILLE, Md., 2013-07-08 16:00 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the approval in Sweden of its prospectus related to its recommended offer to acquire all outstanding shares and warrants (warrants series 2005-I and 2005-II) issued by Isconova AB (the 'Offer'), which was first communicated on June 4, 2013.
Help employers find you! Check out all the jobs and post your resume.
ROCKVILLE, Md., 2013-07-08 16:00 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the approval in Sweden of its prospectus related to its recommended offer to acquire all outstanding shares and warrants (warrants series 2005-I and 2005-II) issued by Isconova AB (the 'Offer'), which was first communicated on June 4, 2013.
Help employers find you! Check out all the jobs and post your resume.